Exercise of Warrants
(WorldNews Finland)

Faron Pharmaceuticals Oy (`Faron` or the `Company`) Exercise of Warrants Issue of Equity TURKU - FINLAND, 27 April 2017- Faron Pharmaceuticals Ltd (`Faron`) (LON: FARN), the clinical stage biopharmaceutical company, announces that it has received a notification from a warrant holder to exercise warrants over 38,430 ordinary shares in the Company at an exercise price of EUR1.55 per share and a further 14,560 ordinary shares in the Company at an exercise price of EUR2.01 per share providing the Company with gross proceeds of EUR88,832.10 (approximately £75,518). Application will be made to the London Stock Exchange to admit the 52,990 new ordinary shares to trading on AIM. Admission of the new...